Healthequity (NASDAQ:HQY) had its price objective hoisted by analysts at Robert W. Baird from $49.00 to $61.00 in a report issued on Tuesday. The firm presently has a “neutral” rating on the stock. Robert W. Baird’s target price would indicate a potential downside of 6.81% from the company’s current price. The analysts noted that the move was a valuation call.

A number of other research firms also recently issued reports on HQY. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Friday, December 22nd. Citigroup began coverage on shares of Healthequity in a research report on Thursday, January 4th. They set a “buy” rating on the stock. Chardan Capital upped their target price on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Cantor Fitzgerald restated a “buy” rating and set a $56.00 target price on shares of Healthequity in a research report on Tuesday, December 5th. Finally, JPMorgan Chase & Co. cut their target price on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 24th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $64.80.

How to Become a New Pot Stock Millionaire

Shares of Healthequity (NASDAQ:HQY) opened at $65.46 on Tuesday. Healthequity has a fifty-two week low of $37.62 and a fifty-two week high of $66.25. The company has a market cap of $3,925.65, a PE ratio of 93.54, a price-to-earnings-growth ratio of 2.90 and a beta of 1.46.

In related news, VP Ashley Dreier sold 12,000 shares of the stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $52.00, for a total value of $624,000.00. Following the sale, the vice president now directly owns 17,652 shares in the company, valued at approximately $917,904. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Berkley Capital, Llc sold 350,000 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $52.12, for a total transaction of $18,242,000.00. The disclosure for this sale can be found here. Insiders sold a total of 652,232 shares of company stock worth $34,038,131 over the last quarter. 19.00% of the stock is currently owned by corporate insiders.

Large investors have recently made changes to their positions in the stock. Global X Management Co. LLC raised its position in shares of Healthequity by 180.6% in the 4th quarter. Global X Management Co. LLC now owns 36,601 shares of the company’s stock valued at $1,708,000 after acquiring an additional 23,556 shares during the period. Amussen Hunsaker Associates LLC raised its position in shares of Healthequity by 1.9% in the 3rd quarter. Amussen Hunsaker Associates LLC now owns 237,239 shares of the company’s stock valued at $12,000,000 after acquiring an additional 4,493 shares during the period. Signition LP acquired a new stake in shares of Healthequity in the 4th quarter valued at approximately $348,000. Dixon Hubard Feinour & Brown Inc. VA acquired a new stake in shares of Healthequity in the 3rd quarter valued at approximately $5,071,000. Finally, Dimensional Fund Advisors LP raised its position in shares of Healthequity by 12.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 531,288 shares of the company’s stock valued at $26,872,000 after acquiring an additional 57,855 shares during the period. Institutional investors and hedge funds own 99.62% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The correct version of this piece of content can be read at https://www.watchlistnews.com/healthequity-hqy-pt-raised-to-61-00-at-robert-w-baird/1956150.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.